Paweł Sobczyński

Prof. Paweł Sobczyński

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2001 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
GWGunther Wiesner
Gunther Wiesner
KHKlaus Hoerauf
Klaus Hoerauf
KSKlaus Schroegendorfer
Klaus Schroegendorfer
PSPaweł Sobczyński
Paweł Sobczyński
MHMarion Harth
Marion Harth
HRHugo W. Ruediger
Hugo W. Ruediger
To minimize the possible health risks posed by waste anesthetic gases, the National Institute of Occupational Safety and Health (NIOSH) recommends exposure limits. We investigated the genotoxicity of a previously established occupational exposure exceeding these limits (high-level exposure) and of one within these limits (low-level exposure). Genotoxicity was assessed by the formation of micronucleated lymphocytes in 25 anesthetists and anesthetic nurses of an Eastern European (High-Level Exposure Group) and a German (Low-Level Exposure Group) university hospital. Each exposed group was compared with a group of nonexposed personnel of the same hospital. Compared with its Control Group, there was an increased fraction of micronucleated lymphocytes per 1000 binucleated cells in the High-Level Exposure Group (median 14.0, range 9.0–26.7 vs median 11.3, range 3.2–19.4;P < 0.05) but not in the Low-Level Exposure Group (median 9.8, range 4.2–20.0 vs median 10.5, range 5.0–20.5). We conclude that a high-level exposure to inhaled anesthetics is associated with an increase in chromosome damage, and measures are recommended to decrease exposure levels. As evidenced by the formation of micronucleated lymphocytes, the threshold values recommended by NIOSH appear to be safe. A high level of occupational exposure to inhaled anesthetics is associated with genotoxicity (as defined by formation of micronucleated lymphocytes), whereas a low-level exposure (within National Institute of Occupational Safety and Health limits) is not.

1 January 2012 in Pharmacological Reports
Verified
Journal Article
Closed access
PWPaweł Wiczling
Paweł Wiczling
Agnieszka BienertAgnieszka Bienert
Agnieszka Bienert
PSPaweł Sobczyński
Paweł Sobczyński
RHRoma Hartmann-Sobczyńska
Roma Hartmann-Sobczyńska
KBKrzysztof Bieda
Krzysztof Bieda
EGEdmund Grześkowiak
Edmund Grześkowiak

21 December 2015 in Journal of Applied Genetics
Verified
Journal Article
Open access
PDF file
KSKrzysztof Szyfter
Krzysztof Szyfter
ISIreneusz Stachecki
Ireneusz Stachecki
MKMagdalena Kostrzewska-Poczekaj
Magdalena Kostrzewska-Poczekaj
MSMarcin Szaumkessel
Marcin Szaumkessel
JSJoanna Szyfter-Harris
Joanna Szyfter-Harris
PSPaweł Sobczyński
Paweł Sobczyński
Volatile anaesthetics such as halothane, isoflurane and others were expected to produce a health challenge for operation room personnel because of prolonged occupational exposure to anaesthetic gases. To estimate a molecular background of adverse health effects, a cohort of 100 exposed individuals was studied by the single-cell gene electrophoresis (comet assay) test. DNA lesions in lymphocytes of the exposed group did not differ significantly compared with non-exposed blood donors. Then, the exposed group was further divided according to job position. A highest level of DNA lesions was established in nurses but without significant difference compared with other groups. When a time period of exposure was taken into account, a tendency to cumulate DNA lesions was found only in the group of anaesthesiologists. A very weak genotoxic effect established in this study is discussed in relation to DNA repair, adaptative response and potential self-elimination of sensitive individuals.

22 November 2000 in International Archives of Occupational and Environmental Health
Verified
Journal Article
Closed access
PDF file
GWG. Wiesner
G. Wiesner
MHM. Harth
M. Harth
RSR. Szulc
R. Szulc
WJW. Jurczyk
W. Jurczyk
PSPaweł Sobczyński
Paweł Sobczyński
KTK. Taeger
K. Taeger

1 August 2000 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
GWG. Wiesner
G. Wiesner
MHM. Harth
M. Harth
KHK. Hoerauf
K. Hoerauf
RSR. Szulc
R. Szulc
WJW. Jurczyk
W. Jurczyk
KTK. Taeger
K. Taeger

17 March 2016 in Biopharmaceutics & Drug Disposition
Verified
Journal Article
Closed access
PDF file
PWPaweł Wiczling
Paweł Wiczling
KBKrzysztof Bieda
Krzysztof Bieda
KPKrzysztof Przybyłowski
Krzysztof Przybyłowski
RHRoma Hartmann‐Sobczyńska
Roma Hartmann‐Sobczyńska
ABAgnieszka Borsuk
Agnieszka Borsuk
Agnieszka BienertAgnieszka Bienert
Agnieszka Bienert